All Type of News
Qurient acquires U.S. approval of Phase II clinical trial for MDR TB therapy Telacebec
Qurient(CEO Ki-Yeon Nam) announced a beginning of a Phase II clinical to globally develop a multi-drug resistant(MDR) tuberculosis(TB) therapy on the 17th of July.
Qurient said the company will start the Phase II cli...
Series of pharmas violating drug small-packaging regulation receive administrative measures
The government has imposed a series of administrative measures on pharmaceutical companies which violate standards of the drug small-packaging system.
The Ministry of Food and Drug Safety(MFDS) imposed administrative...
“Central Procurement Method needs changes to stably supply vaccines for NIP”
It was suggested that the ‘Central Procurement Method’ which takes charge in purchase, distribution and procurement of vaccines for the Korean National Immunization Program(NIP), needed to be changed.
It was also ana...
AstraZeneca to discover new drugs through ‘open innovation’
Multinational pharmaceutical company AstraZeneca seems to expand its pipelines by actively taking open innovation activities to develop new drugs.
AstraZeneca Korea held the ‘ASK AZK 2018’ with medical journalists on...
22 members of Health and Welfare Committee decided
22 members were selected for the Health and Welfare Committee at the second half of the 20th National Assembly.
Health and Welfare Commissioner was decided with Rep. Myung-Soo Lee, and administrative members from rul...
"There are KRW 6 billion multinational pharmas’ medicines stocked at 19 companies"
The Korean Pharmaceutical Association and the Korea Pharmaceutical Distribution Association will take joint actions on multinational companies’ disused and stocked medicines.
The Korean Pharmaceutical Association(KPA...
KPA requests revocation of registration on 24/7 convenient stores selling drugs
The Korea Pharmaceutical Association(President Chan-Whi Cho, KPA) requested local governments to immediately revoke registration on convenient stores which do not sell drugs for 24/7 even though they are registered to...
Ruling and opposing parties to urges immediate actions on ‘Valsartan’ incident
When it comes to the recently-issued Chinese Valsartan case, ruling and opposing parties at the National Assembly have urged systematic improvements, such as prompt safe responses on patients and inspection on foreign...
Valsartan case containing carcinogenic substances will bring negative impacts
Started with the Valsartan case, conflicts between doctors and pharmacists have led to discussions about rebates for pharmaceutical companies.
Doctors have opposed to the international proprietary names – this has be...
List of hospitals and clinics with false insurance claims to be declared
The list of hospitals and clinics which took between KRW 30 million to KRW 200 million by falsely making claims for health insurance benefits will be unveiled.
The Ministry of Health and Welfare(Minister Neung-Hoo Pa...
